Health Care · Pharmaceutical Preparations · NYSE · CIK 353278 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $51.58Day +1.22%1Y +0.3%Off 52W high −19.6%Vol (1Y) 52.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 6,679 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.7% of sh out |
| Days to cover3.3d |
| 13F net flow (QoQ)−0.22% |
| Top-10 13F concentration38.7% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)DKK 309.06B |
| Earnings (TTM)DKK 102.43B |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (DKK). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+5.1% |
| 1Y+0.3% |
| 3Y−30.7% |
| 5Y+25.7% |
| 10Y+128.0% |
| Since incept. (ann.)+16.9% |
Total return through 2026-07-29 · series begins 2000-01-03. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)52.0% |
| Ann. volatility (3Y)43.8% |
| Sharpe (1Y)−0.20 |
| Sharpe (3Y)−0.04 |
| Max drawdown (1Y)−47.2% |
| Max drawdown (3Y)−74.7% |
| Beta (3Y vs SPY)0.89 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Dodge & Cox | 19.3M | $711M | 0.44% | new |
| LOOMIS SAYLES & CO L P | 17.0M | $625M | 0.38% | −0.7% |
| FRANKLIN RESOURCES INC | 16.1M | $591M | 0.36% | +9.4% |
| Capital International Investors | 11.8M | $425M | 0.27% | +5.2% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11.1M | $408M | 0.25% | +808.8% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11.1M | $406M | 0.25% | +14.2% |
| DIAMANT ASSET MANAGEMENT, INC. | 401,310 | $401M | 0.01% | +2030.1% |
| MORGAN STANLEY | 10.9M | $399M | 0.24% | −15.4% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for NVO.
